These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2904419)

  • 1. Endometrial biopsies during treatment with subcutaneous pulsatile gonadotropin-releasing hormone and luteal-phase human chorionic gonadotropin.
    Campbell BF; Phipps WR; Nagel TC; Tagatz GE
    Int J Fertil; 1988; 33(5):329-33. PubMed ID: 2904419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists.
    Saadat P; Boostanfar R; Slater CC; Tourgeman DE; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2004 Jul; 82(1):167-71. PubMed ID: 15237007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
    Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
    Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteal phase evaluation after clomiphene-chorionic gonadotrophin-induced ovulation.
    Balasch J; Vanrell JA; Durán M; González-Merlo J
    Int J Fertil; 1983; 28(2):104-6. PubMed ID: 6136471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovulation induction with pulsatile intravenous GnRH.
    Malo JW; Bezdicek B; Campbell E; Pavelka DA; Covato T
    J Reprod Med; 1985 Dec; 30(12):902-6. PubMed ID: 3908673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovulation induction with subcutaneous pulsatile gonadotropin-releasing hormone: the role of supplemental human chorionic gonadotropin in the luteal phase.
    Weinstein FG; Seibel MM; Taymor ML
    Fertil Steril; 1984 Apr; 41(4):546-50. PubMed ID: 6368272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of every-other-day administration of gonadotropin-releasing hormone in women with hypothalamic amenorrhea: gonadotropin-releasing hormone treatment can induce clomiphene responsiveness.
    Kotsuji F; Aso T; Kamitani N; Tominaga T; Kitaguchi M; Okamura Y
    Obstet Gynecol; 1988 Apr; 71(4):615-21. PubMed ID: 3281077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolongation of follicular phase by delaying hCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles.
    Kolibianakis EM; Bourgain C; Papanikolaou EG; Camus M; Tournaye H; Van Steirteghem AC; Devroey P
    Hum Reprod; 2005 Sep; 20(9):2453-6. PubMed ID: 15890735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of functional infertility, caused by luteal deficiency, with pulsatile perfusion of gonadotropin releasing hormone].
    Koloszár S; Bártfai G; Sas M
    Orv Hetil; 1989 Dec; 130(51):2737-9. PubMed ID: 2689956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of gonadotropin-releasing hormone agonists and antagonists on luteal function.
    DiLuigi AJ; Nulsen JC
    Curr Opin Obstet Gynecol; 2007 Jun; 19(3):258-65. PubMed ID: 17495643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corpus luteal insufficiency.
    Dawood MY
    Curr Opin Obstet Gynecol; 1994 Apr; 6(2):121-7. PubMed ID: 8193250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteal phase estradiol and pregnancy outcome in gonadotropin releasing hormone agonist/human menopausal gonadotropin-treated gamete intrafallopian transfer cycles.
    Molo MW; Rawlins RG; Binor Z; Kelly M; Radwanska E
    J Reprod Med; 1995 Jun; 40(6):418-22. PubMed ID: 7650652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovulation induction in clomiphene nonresponsive patients: the place of pulsatile gonadotropin-releasing hormone in clinical practice.
    Molloy BG; Hancock KW; Glass MR
    Fertil Steril; 1985 Jan; 43(1):26-33. PubMed ID: 3917407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corpora lutea induced by gonadotrophin-releasing hormone treatment of anoestrous Welsh Mountain ewes: reduced sensitivity to luteinizing hormone in vivo and to chorionic gonadotrophin in vitro.
    Bramley TA; Stirling D; Menzies GS; Baird DT
    Reproduction; 2005 Jan; 129(1):61-73. PubMed ID: 15615899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulsatile GnRH therapy for the induction of ovulation in hypogonadotropic hypogonadism.
    Blunt SM; Butt WR
    Acta Endocrinol Suppl (Copenh); 1988; 288():58-65. PubMed ID: 3138867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of ovulation induction therapies on endometrial integrin alpha v beta 3 expression in patients with polycystic ovarian syndrome related infertility].
    Wang Y; Chen Y; Li M
    Zhonghua Fu Chan Ke Za Zhi; 2000 Mar; 35(3):163-5. PubMed ID: 11775896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal LHRH agonist (Buserelin) after ovulation: a post-coital contraceptive approach.
    Lemay A; Faure N; Labrie F; Fazekas AT
    Contracept Deliv Syst; 1983 Apr; 4(2):107-25. PubMed ID: 12338631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations in L-selectin ligand expression in the luteal-phase endometrium after final oocyte maturation with human chorionic gonadotropin compared with a gonadotropin-releasing hormone agonist.
    Lipari CW; Zhao Y; King JA; Alexander CJ; Bankowski BB; Lai TH; Garcia J; Vlahos NP
    Fertil Steril; 2008 Sep; 90(3):876-8. PubMed ID: 17765234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Onset and maintenance of the luteal phase with GnRH agonists or hCG in cycles under GnRH antagonists].
    Olivennes F
    J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S24-6. PubMed ID: 15643682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.